{"id":2166,"date":"2020-09-16T14:32:00","date_gmt":"2020-09-16T14:32:00","guid":{"rendered":"https:\/\/negargetni.com\/?p=2166"},"modified":"2024-09-04T08:50:12","modified_gmt":"2024-09-04T08:50:12","slug":"communique-de-mise-a-disposition-de-la-note-dinformation-et-du-document-autres-informations-relatives-aux-caracteristiques-notamment-juridiques-financieres-et-comptables-de-la","status":"publish","type":"post","link":"https:\/\/integragen.com\/en\/toutes-les-categories\/communique-de-mise-a-disposition-de-la-note-dinformation-et-du-document-autres-informations-relatives-aux-caracteristiques-notamment-juridiques-financieres-et-comptables-de-la\/","title":{"rendered":"ANNOUNCEMENT OF THE AVAILABILITY OF THE INFORMATION MEMORANDUM AND THE DOCUMENT \"OTHER INFORMATION CONCERNING THE LEGAL, FINANCIAL AND ACCOUNTING CHARACTERISTICS\" OF ONCODNA S.A."},"content":{"rendered":"<p><\/p>\n\n\n\n<p>This press release has been prepared and issued by OncoDNA S.A. in accordance with the provisions of Articles 231-27 1\u00b0 and 2\u00b0 and 231-28 of the General Regulations of the Autorit\u00e9 des march\u00e9s financiers (the \"AMF\").\u00a0<strong>AMF\u00a0<\/strong>\").<\/p>\n\n\n\n<p><a href=\"https:\/\/integragen.com\/wp-content\/uploads\/2020-09-16-communique-note-d_information-et-autres-informations.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">To the press release<\/a><\/p>\n\n\n\n<p>.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity is-style-wide\"\/>\n\n\n\n<p>September 16, 2020<\/p>\n\n\n\n<p>Share :<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity is-style-wide\"\/>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/integragen.com\/en\/fr\/communiques-de-presse\/assemblee-generale-mixte\/\">COMBINED GENERAL MEETING<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/integragen.com\/en\/fr\/communiques-de-presse\/integragen-1s-2020\/\">IntegraGen - 1st half 2020 results<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>This press release has been prepared and distributed by OncoDNA S.A. in accordance with the provisions of articles 231-27 1\u00b0 and 2\u00b0 and 231-28 of the general regulations of the Autorit\u00e9 des march\u00e9s financiers (the \"AMF\"). To the press release . September 16, 2020 Share :<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"ca_portfolio_gallery_project_year":"","ca_portfolio_gallery_client":"","ca_portfolio_gallery_skills":"","ca_portfolio_gallery_url":"","ca_portfolio_gallery_images":"","_eb_attr":"","footnotes":""},"categories":[6,1],"tags":[],"class_list":["post-2166","post","type-post","status-publish","format-standard","hentry","category-communiques-de-presse","category-toutes-les-categories"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>COMMUNIQU\u00c9 DE MISE A DISPOSITION DE LA NOTE D\u2019INFORMATION ET DU DOCUMENT \u00ab AUTRES INFORMATIONS RELATIVES AUX CARACT\u00c9RISTIQUES, NOTAMMENT JURIDIQUES, FINANCI\u00c8RES ET COMPTABLES \u00bb DE LA SOCI\u00c9T\u00c9 ONCODNA S.A.<\/title>\n<meta name=\"description\" content=\"Le pr\u00e9sent communiqu\u00e9 a \u00e9t\u00e9 \u00e9tabli et diffus\u00e9 par la soci\u00e9t\u00e9 OncoDNA S.A. en application des dispositions des articles 231-27 1\u00b0 et 2\u00b0 et 231-28 du\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/integragen.com\/en\/toutes-les-categories\/communique-de-mise-a-disposition-de-la-note-dinformation-et-du-document-autres-informations-relatives-aux-caracteristiques-notamment-juridiques-financieres-et-comptables-de-la\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"COMMUNIQU\u00c9 DE MISE A DISPOSITION DE LA NOTE D\u2019INFORMATION ET DU DOCUMENT \u00ab AUTRES INFORMATIONS RELATIVES AUX CARACT\u00c9RISTIQUES, NOTAMMENT JURIDIQUES, FINANCI\u00c8RES ET COMPTABLES \u00bb DE LA SOCI\u00c9T\u00c9 ONCODNA S.A.\" \/>\n<meta property=\"og:description\" content=\"Le pr\u00e9sent communiqu\u00e9 a \u00e9t\u00e9 \u00e9tabli et diffus\u00e9 par la soci\u00e9t\u00e9 OncoDNA S.A. en application des dispositions des articles 231-27 1\u00b0 et 2\u00b0 et 231-28 du\" \/>\n<meta property=\"og:url\" content=\"https:\/\/integragen.com\/en\/toutes-les-categories\/communique-de-mise-a-disposition-de-la-note-dinformation-et-du-document-autres-informations-relatives-aux-caracteristiques-notamment-juridiques-financieres-et-comptables-de-la\/\" \/>\n<meta property=\"og:site_name\" content=\"IntegraGen\" \/>\n<meta property=\"article:published_time\" content=\"2020-09-16T14:32:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-04T08:50:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/integragen.com\/wp-content\/uploads\/2024\/07\/image-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"2478\" \/>\n\t<meta property=\"og:image:height\" content=\"684\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"borel\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"borel\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/communique-de-mise-a-disposition-de-la-note-dinformation-et-du-document-autres-informations-relatives-aux-caracteristiques-notamment-juridiques-financieres-et-comptables-de-la\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/communique-de-mise-a-disposition-de-la-note-dinformation-et-du-document-autres-informations-relatives-aux-caracteristiques-notamment-juridiques-financieres-et-comptables-de-la\\\/\"},\"author\":{\"name\":\"borel\",\"@id\":\"https:\\\/\\\/integragen.com\\\/#\\\/schema\\\/person\\\/f6280b21a3de1be99b206a61b1b27cd8\"},\"headline\":\"COMMUNIQU\u00c9 DE MISE A DISPOSITION DE LA NOTE D\u2019INFORMATION ET DU DOCUMENT \u00ab AUTRES INFORMATIONS RELATIVES AUX CARACT\u00c9RISTIQUES, NOTAMMENT JURIDIQUES, FINANCI\u00c8RES ET COMPTABLES \u00bb DE LA SOCI\u00c9T\u00c9 ONCODNA S.A.\",\"datePublished\":\"2020-09-16T14:32:00+00:00\",\"dateModified\":\"2024-09-04T08:50:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/communique-de-mise-a-disposition-de-la-note-dinformation-et-du-document-autres-informations-relatives-aux-caracteristiques-notamment-juridiques-financieres-et-comptables-de-la\\\/\"},\"wordCount\":92,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/integragen.com\\\/#organization\"},\"articleSection\":[\"Communiqu\u00e9s de presse\",\"Toutes les Cat\u00e9gories\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/communique-de-mise-a-disposition-de-la-note-dinformation-et-du-document-autres-informations-relatives-aux-caracteristiques-notamment-juridiques-financieres-et-comptables-de-la\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/communique-de-mise-a-disposition-de-la-note-dinformation-et-du-document-autres-informations-relatives-aux-caracteristiques-notamment-juridiques-financieres-et-comptables-de-la\\\/\",\"url\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/communique-de-mise-a-disposition-de-la-note-dinformation-et-du-document-autres-informations-relatives-aux-caracteristiques-notamment-juridiques-financieres-et-comptables-de-la\\\/\",\"name\":\"COMMUNIQU\u00c9 DE MISE A DISPOSITION DE LA NOTE D\u2019INFORMATION ET DU DOCUMENT \u00ab AUTRES INFORMATIONS RELATIVES AUX CARACT\u00c9RISTIQUES, NOTAMMENT JURIDIQUES, FINANCI\u00c8RES ET COMPTABLES \u00bb DE LA SOCI\u00c9T\u00c9 ONCODNA S.A.\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/integragen.com\\\/#website\"},\"datePublished\":\"2020-09-16T14:32:00+00:00\",\"dateModified\":\"2024-09-04T08:50:12+00:00\",\"description\":\"Le pr\u00e9sent communiqu\u00e9 a \u00e9t\u00e9 \u00e9tabli et diffus\u00e9 par la soci\u00e9t\u00e9 OncoDNA S.A. en application des dispositions des articles 231-27 1\u00b0 et 2\u00b0 et 231-28 du\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/communique-de-mise-a-disposition-de-la-note-dinformation-et-du-document-autres-informations-relatives-aux-caracteristiques-notamment-juridiques-financieres-et-comptables-de-la\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/communique-de-mise-a-disposition-de-la-note-dinformation-et-du-document-autres-informations-relatives-aux-caracteristiques-notamment-juridiques-financieres-et-comptables-de-la\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/communique-de-mise-a-disposition-de-la-note-dinformation-et-du-document-autres-informations-relatives-aux-caracteristiques-notamment-juridiques-financieres-et-comptables-de-la\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/integragen.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Communiqu\u00e9s de presse\",\"item\":\"https:\\\/\\\/integragen.com\\\/communiques-de-presse\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"COMMUNIQU\u00c9 DE MISE A DISPOSITION DE LA NOTE D\u2019INFORMATION ET DU DOCUMENT \u00ab AUTRES INFORMATIONS RELATIVES AUX CARACT\u00c9RISTIQUES, NOTAMMENT JURIDIQUES, FINANCI\u00c8RES ET COMPTABLES \u00bb DE LA SOCI\u00c9T\u00c9 ONCODNA S.A.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/integragen.com\\\/#website\",\"url\":\"https:\\\/\\\/integragen.com\\\/\",\"name\":\"IntegraGen - Clinical Genomic Experts\",\"description\":\"NGS Sequencing &amp; Bioinformatics for Pharma, Biotech &amp; CRO\",\"publisher\":{\"@id\":\"https:\\\/\\\/integragen.com\\\/#organization\"},\"alternateName\":\"IntegraGen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/integragen.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/integragen.com\\\/#organization\",\"name\":\"IntegraGen\",\"url\":\"https:\\\/\\\/integragen.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/integragen.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/integragen.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/Logo_IntegraGen_OncoDNA.png\",\"contentUrl\":\"https:\\\/\\\/integragen.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/Logo_IntegraGen_OncoDNA.png\",\"width\":2478,\"height\":684,\"caption\":\"IntegraGen\"},\"image\":{\"@id\":\"https:\\\/\\\/integragen.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/integragen\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/integragen.com\\\/#\\\/schema\\\/person\\\/f6280b21a3de1be99b206a61b1b27cd8\",\"name\":\"borel\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7616457667d003266ce8cf944d45183cc7cbef7ec9a7896861e521289a7e8d87?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7616457667d003266ce8cf944d45183cc7cbef7ec9a7896861e521289a7e8d87?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7616457667d003266ce8cf944d45183cc7cbef7ec9a7896861e521289a7e8d87?s=96&d=mm&r=g\",\"caption\":\"borel\"},\"sameAs\":[\"http:\\\/\\\/nouveausiteintegragen2.local\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ANNOUNCEMENT OF THE AVAILABILITY OF THE INFORMATION MEMORANDUM AND THE DOCUMENT \"OTHER INFORMATION CONCERNING THE LEGAL, FINANCIAL AND ACCOUNTING CHARACTERISTICS\" OF ONCODNA S.A.","description":"Le pr\u00e9sent communiqu\u00e9 a \u00e9t\u00e9 \u00e9tabli et diffus\u00e9 par la soci\u00e9t\u00e9 OncoDNA S.A. en application des dispositions des articles 231-27 1\u00b0 et 2\u00b0 et 231-28 du","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/integragen.com\/en\/toutes-les-categories\/communique-de-mise-a-disposition-de-la-note-dinformation-et-du-document-autres-informations-relatives-aux-caracteristiques-notamment-juridiques-financieres-et-comptables-de-la\/","og_locale":"en_US","og_type":"article","og_title":"COMMUNIQU\u00c9 DE MISE A DISPOSITION DE LA NOTE D\u2019INFORMATION ET DU DOCUMENT \u00ab AUTRES INFORMATIONS RELATIVES AUX CARACT\u00c9RISTIQUES, NOTAMMENT JURIDIQUES, FINANCI\u00c8RES ET COMPTABLES \u00bb DE LA SOCI\u00c9T\u00c9 ONCODNA S.A.","og_description":"Le pr\u00e9sent communiqu\u00e9 a \u00e9t\u00e9 \u00e9tabli et diffus\u00e9 par la soci\u00e9t\u00e9 OncoDNA S.A. en application des dispositions des articles 231-27 1\u00b0 et 2\u00b0 et 231-28 du","og_url":"https:\/\/integragen.com\/en\/toutes-les-categories\/communique-de-mise-a-disposition-de-la-note-dinformation-et-du-document-autres-informations-relatives-aux-caracteristiques-notamment-juridiques-financieres-et-comptables-de-la\/","og_site_name":"IntegraGen","article_published_time":"2020-09-16T14:32:00+00:00","article_modified_time":"2024-09-04T08:50:12+00:00","og_image":[{"width":2478,"height":684,"url":"https:\/\/integragen.com\/wp-content\/uploads\/2024\/07\/image-1.png","type":"image\/png"}],"author":"borel","twitter_card":"summary_large_image","twitter_misc":{"Written by":"borel"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/integragen.com\/toutes-les-categories\/communique-de-mise-a-disposition-de-la-note-dinformation-et-du-document-autres-informations-relatives-aux-caracteristiques-notamment-juridiques-financieres-et-comptables-de-la\/#article","isPartOf":{"@id":"https:\/\/integragen.com\/toutes-les-categories\/communique-de-mise-a-disposition-de-la-note-dinformation-et-du-document-autres-informations-relatives-aux-caracteristiques-notamment-juridiques-financieres-et-comptables-de-la\/"},"author":{"name":"borel","@id":"https:\/\/integragen.com\/#\/schema\/person\/f6280b21a3de1be99b206a61b1b27cd8"},"headline":"COMMUNIQU\u00c9 DE MISE A DISPOSITION DE LA NOTE D\u2019INFORMATION ET DU DOCUMENT \u00ab AUTRES INFORMATIONS RELATIVES AUX CARACT\u00c9RISTIQUES, NOTAMMENT JURIDIQUES, FINANCI\u00c8RES ET COMPTABLES \u00bb DE LA SOCI\u00c9T\u00c9 ONCODNA S.A.","datePublished":"2020-09-16T14:32:00+00:00","dateModified":"2024-09-04T08:50:12+00:00","mainEntityOfPage":{"@id":"https:\/\/integragen.com\/toutes-les-categories\/communique-de-mise-a-disposition-de-la-note-dinformation-et-du-document-autres-informations-relatives-aux-caracteristiques-notamment-juridiques-financieres-et-comptables-de-la\/"},"wordCount":92,"commentCount":0,"publisher":{"@id":"https:\/\/integragen.com\/#organization"},"articleSection":["Communiqu\u00e9s de presse","Toutes les Cat\u00e9gories"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/integragen.com\/toutes-les-categories\/communique-de-mise-a-disposition-de-la-note-dinformation-et-du-document-autres-informations-relatives-aux-caracteristiques-notamment-juridiques-financieres-et-comptables-de-la\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/integragen.com\/toutes-les-categories\/communique-de-mise-a-disposition-de-la-note-dinformation-et-du-document-autres-informations-relatives-aux-caracteristiques-notamment-juridiques-financieres-et-comptables-de-la\/","url":"https:\/\/integragen.com\/toutes-les-categories\/communique-de-mise-a-disposition-de-la-note-dinformation-et-du-document-autres-informations-relatives-aux-caracteristiques-notamment-juridiques-financieres-et-comptables-de-la\/","name":"ANNOUNCEMENT OF THE AVAILABILITY OF THE INFORMATION MEMORANDUM AND THE DOCUMENT \"OTHER INFORMATION CONCERNING THE LEGAL, FINANCIAL AND ACCOUNTING CHARACTERISTICS\" OF ONCODNA S.A.","isPartOf":{"@id":"https:\/\/integragen.com\/#website"},"datePublished":"2020-09-16T14:32:00+00:00","dateModified":"2024-09-04T08:50:12+00:00","description":"Le pr\u00e9sent communiqu\u00e9 a \u00e9t\u00e9 \u00e9tabli et diffus\u00e9 par la soci\u00e9t\u00e9 OncoDNA S.A. en application des dispositions des articles 231-27 1\u00b0 et 2\u00b0 et 231-28 du","breadcrumb":{"@id":"https:\/\/integragen.com\/toutes-les-categories\/communique-de-mise-a-disposition-de-la-note-dinformation-et-du-document-autres-informations-relatives-aux-caracteristiques-notamment-juridiques-financieres-et-comptables-de-la\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/integragen.com\/toutes-les-categories\/communique-de-mise-a-disposition-de-la-note-dinformation-et-du-document-autres-informations-relatives-aux-caracteristiques-notamment-juridiques-financieres-et-comptables-de-la\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/integragen.com\/toutes-les-categories\/communique-de-mise-a-disposition-de-la-note-dinformation-et-du-document-autres-informations-relatives-aux-caracteristiques-notamment-juridiques-financieres-et-comptables-de-la\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/integragen.com\/"},{"@type":"ListItem","position":2,"name":"Communiqu\u00e9s de presse","item":"https:\/\/integragen.com\/communiques-de-presse\/"},{"@type":"ListItem","position":3,"name":"COMMUNIQU\u00c9 DE MISE A DISPOSITION DE LA NOTE D\u2019INFORMATION ET DU DOCUMENT \u00ab AUTRES INFORMATIONS RELATIVES AUX CARACT\u00c9RISTIQUES, NOTAMMENT JURIDIQUES, FINANCI\u00c8RES ET COMPTABLES \u00bb DE LA SOCI\u00c9T\u00c9 ONCODNA S.A."}]},{"@type":"WebSite","@id":"https:\/\/integragen.com\/#website","url":"https:\/\/integragen.com\/","name":"IntegraGen - Clinical Genomic Experts","description":"NGS Sequencing &amp; Bioinformatics for Pharma, Biotech &amp; CROs","publisher":{"@id":"https:\/\/integragen.com\/#organization"},"alternateName":"IntegraGen","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/integragen.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/integragen.com\/#organization","name":"IntegraGen","url":"https:\/\/integragen.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/integragen.com\/#\/schema\/logo\/image\/","url":"https:\/\/integragen.com\/wp-content\/uploads\/2024\/09\/Logo_IntegraGen_OncoDNA.png","contentUrl":"https:\/\/integragen.com\/wp-content\/uploads\/2024\/09\/Logo_IntegraGen_OncoDNA.png","width":2478,"height":684,"caption":"IntegraGen"},"image":{"@id":"https:\/\/integragen.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/integragen\/"]},{"@type":"Person","@id":"https:\/\/integragen.com\/#\/schema\/person\/f6280b21a3de1be99b206a61b1b27cd8","name":"borel","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/7616457667d003266ce8cf944d45183cc7cbef7ec9a7896861e521289a7e8d87?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/7616457667d003266ce8cf944d45183cc7cbef7ec9a7896861e521289a7e8d87?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7616457667d003266ce8cf944d45183cc7cbef7ec9a7896861e521289a7e8d87?s=96&d=mm&r=g","caption":"borel"},"sameAs":["http:\/\/nouveausiteintegragen2.local"]}]}},"_links":{"self":[{"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/posts\/2166","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/comments?post=2166"}],"version-history":[{"count":2,"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/posts\/2166\/revisions"}],"predecessor-version":[{"id":2790,"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/posts\/2166\/revisions\/2790"}],"wp:attachment":[{"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/media?parent=2166"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/categories?post=2166"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/tags?post=2166"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}